Jump to ContentJump to Main Navigation
Show Summary Details
More options …

Open Medicine

formerly Central European Journal of Medicine

Editor-in-Chief: Darzynkiewicz, Zbigniew


IMPACT FACTOR 2018: 1.221

CiteScore 2018: 1.01

SCImago Journal Rank (SJR) 2018: 0.329
Source Normalized Impact per Paper (SNIP) 2018: 0.479

ICV 2018: 156.09

Open Access
Online
ISSN
2391-5463
See all formats and pricing
More options …
Volume 8, Issue 3

Issues

Volume 10 (2015)

Detection of presensitization in recipients of kidney transplants

Nada Vasić / Svetlana Vojvodić / Dušica Ademović-Sazdanić
Published Online: 2013-04-17 | DOI: https://doi.org/10.2478/s11536-012-0086-9
  • [1] Cecka JM., The OPTN/UNOS renal transplant registry, Clin. Transplant., 2005, 1–16 Google Scholar

  • [2] Cecka JM., The OPTN/UNOS Renal Transplant Registry, Clin. Transplant., 2004, 1–16 Google Scholar

  • [3] Amico P., Evolution of graft survival in kidney transplantation: an analysis of the OPTN/UNOS Renal Transplant Registry, Clin. Transplant., 2010, 1–15 Google Scholar

  • [4] Garcia-Garcia G., Harden P., Chapman J., For the world kidney day steering committee 2012., The global role of kidney transplantation, Nephrology., 2012, 17, 199–203 http://dx.doi.org/10.1111/j.1440-1797.2012.01564.xCrossrefGoogle Scholar

  • [5] Persijn GG., Allocation of organs, particularly kidneys, within Eurotransplant, Hum. Immunol., 2006, 67, 419–423 CrossrefGoogle Scholar

  • [6] Mayer G., Persijn GG., Eurotransplant kidney allocation system (ETKAS): rationale and implementation, Nephrol. Dial. Transpl., 2006, 21, 2–3 http://dx.doi.org/10.1093/ndt/gfi269CrossrefGoogle Scholar

  • [7] Hardy S., Lee SH., Terasaki PI., Sensitization 2001, Clin. Transplant., 2001, 271 Google Scholar

  • [8] Peng A., Vo A., Jordan SC., Transplantation of the highly human leukocyte antigen-sensitized patient: Long-term outcomes and future directions, Transplant. Rev., 2006, 20, 46 http://dx.doi.org/10.1016/j.trre.2006.06.002CrossrefGoogle Scholar

  • [9] Warren DS., Montgomery RA., Incompatible kidney transplantation: Lessons from a decade of desensitization and paired kidney exchange, Immunol. Res. 2010, 47, 257 http://dx.doi.org/10.1007/s12026-009-8157-yWeb of ScienceCrossrefGoogle Scholar

  • [10] Eikmans M., Waanders MM., Roelen DL., van Miert PP., Anholts JD., de Fijter HW., et al., Differential effect of pretransplant blood transfusions on immune effector and regulatory compartments in HLA-sensitized and nonsensitized recipients, Transplantation., 2010, 90, 1192–1199 http://dx.doi.org/10.1097/TP.0b013e3181fa943dWeb of ScienceCrossrefGoogle Scholar

  • [11] Nicol D., MacDonald AS., Lawen J., Belitsky P., Early prediction of renal allograft loss beyond one year, Transpl. Int., 1993, 6, 153–157 http://dx.doi.org/10.1111/j.1432-2277.1993.tb00636.xCrossrefGoogle Scholar

  • [12] Stanković B., Taseski J., Balint B., Trkuljić M., Veljančić V., Hrvačević R., et al., Značaj transfuzija krvi za razvoj citotoksičnih antitela kod bolesnika na hemodijalizi, Vojnosanit. Pregl., 2000, 57, 37–41 Google Scholar

  • [13] Balasubramaniam GS., Morris M., Gupta A., Mesa IR., Thuraisingham R., Ashman N., Allosensitization Rate of Male Patients Awaiting First Kidney Grafts After Leuko-Depleted Blood Transfusion, Transplantation., 2012, 93, 418–422 http://dx.doi.org/10.1097/TP.0b013e3182419864CrossrefGoogle Scholar

  • [14] Vaidya S., Synthesis of new and memory HLA antibodies from acute and chronic rejections versus pregnancies and blood transfusions, Transplant. P., 2005, 37, 648–649 http://dx.doi.org/10.1016/j.transproceed.2005.01.067CrossrefGoogle Scholar

  • [15] Scornik JC., Ireland JE., Howard RJ., Pfaff WW., Assessment of the risk for broad sensitization by blood transfusions, Transplantation., 1984, 37, 249 http://dx.doi.org/10.1097/00007890-198403000-00006CrossrefGoogle Scholar

  • [16] Sheldon S., Poulton K., HLA Typing and Its Influence on Organ Transplantation, Methods. Mol. Biol., 2006, 333, 157–174 Google Scholar

  • [17] Petz B., Osnovne statističke metode, Zagreb: Izdanja škole narodnog zdravlja “Andrija Štampar”, 1964, 111–133 Google Scholar

  • [18] Morales-Buenrostro LE., Terasaki PI., Marino-Va’zquez LA., et al., “Natural” human leukocyte antigen antibodies found in nonalloimmunized healthy males, Transplantation., 2008, 86, 1111 http://dx.doi.org/10.1097/TP.0b013e318186d87bCrossrefGoogle Scholar

  • [19] Susal C., Dohler B., Sadeghi M., et al., HLA antibodies and the occurrence of early adverse events in the modern era of transplantation: A collaborative transplant study report, Transplantation., 2009, 87, 1367 http://dx.doi.org/10.1097/TP.0b013e3181a24073CrossrefGoogle Scholar

  • [20] Terasaki PI., Cai J., Human leukocyte antigen antibodies and chronic rejection: From association to causation, Transplantation., 2008, 86, 377 http://dx.doi.org/10.1097/TP.0b013e31817c4cb8CrossrefGoogle Scholar

  • [21] Cecka JM., Zhang Q., Reed EF., Preformed cytotoxic antibodies in potential allograft recipients: recent data, Hum. Immunol., 2005, 66, 343–349 http://dx.doi.org/10.1016/j.humimm.2005.01.030CrossrefGoogle Scholar

  • [22] Wolfe RA., Ashby VB., Milford EL., et al., Comparison of mortality in all patients on dialysis, patients on dialysis awaiting transplantation, and recipients of a first cadaveric transplant, New. Engl. J. Med., 1999, 341, 1725 http://dx.doi.org/10.1056/NEJM199912023412303CrossrefGoogle Scholar

  • [23] Katznelson S., Bhaduri S., Cecka JM., Clinical aspects of sensitization, Clin. Transplant., 1997, 285–296 Google Scholar

  • [24] Hrvačević R., et al., Predijalizna transplantacija bubrega, Vojnosanit. Pregl., 2002, 59, 423–427 http://dx.doi.org/10.2298/VSP0204423HCrossrefGoogle Scholar

  • [25] Sanfilippo FP., Bollinger RR., MacQueen JM., Brooks BJ., Koepke JA., A randomized study comparing leukocyte-depleted versus packed red cell transfusions in prospective cadaver renal allograft recipients, Transfusion., 1985, 25, 116–119 http://dx.doi.org/10.1046/j.1537-2995.1985.25285169200.xCrossrefGoogle Scholar

  • [26] Karpinski M., Pochinco D., Dembinski I., Laidlaw W., Zacharias J., Nickerson P., Leukocyte reduction of red blood cell transfusions does not decrease allosensitization rates in potential kidney transplant candidates, J. Am. Soc. Nephrol., 2004, 15, 818–824 http://dx.doi.org/10.1097/01.ASN.0000115399.80913.B1CrossrefGoogle Scholar

  • [27] Vamvakas EC., Meta-analysis of randomized controlled trials of the efficacy of white cell reduction in preventing HLA-alloimmunization and refractoriness to random-donor platelet transfusions, Transfus. Med. Rev., 1998, 12, 258–270 http://dx.doi.org/10.1016/S0887-7963(98)80002-3CrossrefGoogle Scholar

  • [28] Scornik JC., Meier-Kriesche H-U., Blood Transfusions in Organ Transplant Patients: Mechanisms of Sensitization and Implications for Prevention, Am. J. Transplant., 2011, 11, 1785–1791 http://dx.doi.org/10.1111/j.1600-6143.2011.03705.xCrossrefGoogle Scholar

  • [29] Bilgin YM., van de Watering LM., Brand A., Clinical effects of leucoreduction of blood transfusions, Neth. J. Med., 2011, 69(10), 441–450 Google Scholar

  • [30] Marfo K., Lu A., Ling M., Akalin E., Desensitization protocols and their outcome, Clin. J. Am. Soc. Nephro., 2011, 6, 922–936 http://dx.doi.org/10.2215/CJN.08140910CrossrefGoogle Scholar

About the article

Published Online: 2013-04-17

Published in Print: 2013-06-01


Citation Information: Open Medicine, Volume 8, Issue 3, Pages 310–316, ISSN (Online) 2391-5463, DOI: https://doi.org/10.2478/s11536-012-0086-9.

Export Citation

© 2013 Versita Warsaw. This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License. BY-NC-ND 3.0

Comments (0)

Please log in or register to comment.
Log in